Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.30 |
| ▸ | DRD3 | P35462 | 2/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9320159 | 0.89 | PAOX (0.34) | ALDH1A1 | |
| SCHEMBL13260026 | 0.82 | MEN1 (0.35) | ALDH1A1 | |
| SCHEMBL10833650 | 0.81 | IMPDH2 (0.33) | TGFBR1 | |
| SCHEMBL10424781 | 0.80 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL3422991 | 0.79 | ALDH1A1 (0.34) | ALDH1A1TGFBR1 | |
| SCHEMBL6462038 | 0.79 | ALDH1A1 (0.34) | ALDH1A1TGFBR1 | |
| SCHEMBL8210939 | 0.79 | TGFBR1 (0.37) | ALDH1A1TGFBR1 | |
| SCHEMBL6232119 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TGFBR1 | |
| SCHEMBL19881206 | 0.78 | TGFBR1 (0.34) | ALDH1A1TGFBR1 | |
| SCHEMBL19881205 | 0.77 | ALDH1A1 (0.37) | ALDH1A1TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-58017827-A | — | — | None | — | — | JP | disclosed |
| EP-2124869-B1 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | OREAL (FR) | 2012-08-15 | — | — | EP | disclosed |
| US-20100166844-A1 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | L'OREAL S.A. (FR) | 2010-07-01 | — | — | US | disclosed |
| US-20100166844-A1 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | L'OREAL S.A. (FR) | 2010-07-01 | — | — | US | disclosed |
| WO-2008104698-A2 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | L'OREAL (FR) | 2008-09-04 | — | — | WO | disclosed |
| EP-1174444-B1 | Dispersion stablizer for suspension polymerization of vinyl compound | KURARAY CO LTD KURASHIKI PLANT (JP) | 2008-05-21 | — | — | EP | disclosed |
| US-7175892-B2 | Emulsion and coating liquid and recording medium using the same | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2007-02-13 | — | — | US | disclosed |
| EP-1426195-B1 | Ink jet recording element | EASTMAN KODAK CO (US) | 2006-03-08 | — | — | EP | disclosed |
| EP-1474719-A4 | POLYMERIZATION PROCESS AND MATERIALS FOR BIOMEDICAL APPLICATIONS | ZMS LLC (US) | 2005-12-14 | — | — | EP | disclosed |
| EP-1300421-B1 | Dispersion stabilizer for suspension polymerization of vinyl compound | KURARAY CO (JP) | 2005-08-31 | — | — | EP | disclosed |
| WO-2003071339-A1 | POLYMERIZATION PROCESS AND MATERIALS FOR BIOMEDICAL APPLICATIONS | ZMS, LLC (US) | 2003-08-28 | — | — | WO | disclosed |
| US-20030092835-A1 | Dispersion stabilizer for suspension polymerization of vinyl compound | KURARAY CO. LTD. (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-1300421-A1 | Dispersion stabilizer for suspension polymerization of vinyl compound | KURARAY CO., LTD. (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-20030020870-A1 | Biomedical molding materials from semi-solid precursors | ZMS, LLC | 2003-01-30 | — | — | US | disclosed |
| WO-2003003073-A1 | BIOMEDICAL MOLDING MATERIALS FROM SEMI-SOLID PRECURSORS | ZMS, LLC (US) | 2003-01-09 | — | — | WO | disclosed |
| US-20030008972-A1 | Dispersion stabilizer for suspension polymerization of vinyl compound | KURARAY CO. LTD. (JP) | 2003-01-09 | — | — | US | disclosed |
| US-20020045706-A1 | Biomedical molding materials from semi-solid precursors | ZMS, LLC | 2002-04-18 | — | — | US | disclosed |
| EP-1174444-A1 | Dispersion stablizer for suspension polymerization of vinyl compound | Kuraray Co., Ltd., Kurashiki Plant (JP) | 2002-01-23 | — | — | EP | disclosed |
| JP-S5817827-A | AQUEOUS DISPERSION SOLUTION | KURARAY CO LTD | 1983-02-02 | — | — | JP | disclosed |
| JP-S05817827-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100166844-A1 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | KRT18, KRTCAP2, DSG1 | ALDH1A1 2706/4885TGFBR1 3627/4885OPRM1 4060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.